Randomized trial comparing three different regimens of alpha‐2a‐interferon in chronic hepatitis C
Liliana Chemello, Paola Bonetti, Luisa Cavalletto, Fabiola Talato, Valter Donadon, Pietro Casarin, Fabio Belussi, Mario Frezza, Franco Noventa, Patrizia Pontisso, Luisa Benvegnù, Carla Casarin, Alfredo Alberti, The TriVeneto Viral Hepatitis Group – 1 September 1995 – Alpha‐interferon (IFN‐α) is an effective treatment for chronic hepatitis C, but only 20% to 30% of patients are apparently cured with the currently recommended schedule of 3 MU given three times a week for 6 months.